The sign hasn't changed. Same address, same parking lot, maybe even the same doctor you've been bringing your cat to for seven years. But the clinic you walk into no longer belongs to the person who opened it thirty years ago. It belongs to a fund you've never heard of — one that bought this clinic along with three hundred others, precisely because your trust in "the family vet" turned out to be one of the most underpriced assets in healthcare.
It's called a roll-up. And over the last fifteen years, it has quietly rewritten who actually owns the care your animal receives.
The mechanics of the buy-up
The scheme is as simple as anything genuinely profitable tends to be. Private equity doesn't buy one clinic — it buys a "platform": a large chain or an already-established brand, then uses that platform as an engine to acquire independent practices one after another, dozens and then hundreds at a time. In finance jargon this is a "tuck-in." A small clinic disappears inside the larger structure, but almost nothing changes on the outside: same name on the door, same logo on the letterhead.
That is the entire calculation. A pet owner doesn't choose a clinic by its ownership structure — they choose it by a feeling: this is a place I trust. A roll-up monetizes exactly that feeling without touching its shell. What changes is not the sign. What changes is everything behind it: drug purchasing gets centralized, prices for visits and procedures drift upward in lockstep across the network, vets get assigned internal revenue-per-visit targets, and decisions a practice owner used to make on their own judgment now come down from a corporate protocol.
Who's holding the leash
The names aren't hard to list — there aren't many, and they repeat state to state. Mars, Incorporated — yes, the chocolate-bar and pet-food company — is one of the largest owners of veterinary care on earth: it owns Banfield Pet Hospital (the clinics inside PetSmart stores), BluePearl (emergency and specialty care), and VCA Animal Hospitals, acquired in 2017 for roughly $9 billion. Through VCA, Mars also owns Antech, one of the largest veterinary diagnostic-lab networks — meaning it controls both the clinic and the lab that clinic sends your pet's bloodwork to.
JAB Holding, the investment vehicle of Germany's Reimann family — the same fund behind Keurig Dr Pepper, Panera, and half the coffee brands on a supermarket shelf — spent a few years assembling National Veterinary Associates (NVA), Compassion-First Pet Hospitals, and several other chains into one of the largest private players in North American veterinary care. In Europe, IVC Evidensia, backed by Swedish capital and several major PE funds, plays a similar role, growing to thousands of clinics across dozens of countries with the same method: buy small, keep the sign, centralize everything else.
By various estimates, the share of U.S. clinics owned by corporate chains has grown from the low single digits a couple of decades ago to roughly a quarter of the market today — and in emergency and specialty care, where a pet owner has no time to shop around, that share runs noticeably higher than half. In 2024, the U.S. Federal Trade Commission publicly requested acquisition data from veterinary chains, including entities tied to JAB — the request itself says more about the scale of consolidation than any press-release figure would.
The sign stays the same; everything else doesn't
This isn't about a malicious chain manager somewhere. It's about what happens to a decision the moment it starts getting measured. An independent vet orders a test because they think this specific animal needs it, and can quietly waive a fee if a family is visibly struggling to pay. A vet inside a chain with a quarterly revenue-per-visit target is working inside a system where that same decision has already been partially made for them: a protocol recommends a certain panel of tests, a loyalty program nudges toward the upsell, and the vet's own performance as an employee is measured in dollars per visit, not outcomes for the patient.
That doesn't make the vet a bad person. It means the incentive they now operate under was engineered not for your cat's wellbeing but for the return of a fund sitting two or three layers above the clinic — a fund that in turn answers to pension money and endowments demanding growth, the same chain that pulls rent out of houses and prices out of medicine.
Our record: the ledger doesn't ask whether you love your dog. It asks how much flow can be run through the appointment. Caring for a living creature is one of the last Sekhem a person still holds personally, outside the market — a direct act of responsibility for another life with no intermediary. A roll-up doesn't cancel that act; it intercepts it: it leaves you the feeling that you chose the vet yourself, while quietly taking over the mechanism that decides. Shadow Thoth doesn't lie here outright — it just makes sure the "family clinic" sign outlasts the fact.
Where the lever is
Ask directly who owns the clinic. Vets inside corporate chains aren't legally required to hide this, and most will answer honestly if you ask plainly: "Is this an independent practice, or part of a network?" The chain names — NVA, Compassion-First, VCA, Banfield, IVC Evidensia, Thrive — are searchable in advance, not something you should learn from the bill afterward.
Compare estimates before, not after. A quote for a comparable procedure at a corporate-owned clinic can differ noticeably from an independent one in the same city — ask for a written estimate up front, and don't hesitate to take it elsewhere.
Seek out an independent clinic deliberately, not out of habit toward an old address. It pays the same rent and the same drug prices, but without a layer of corporate targets sitting between you and the vet's judgment — and every visit you make there literally keeps an alternative to the roll-up model alive, not just saves you a few dollars once.
Trust in the person treating your animal shouldn't be a line item in someone else's return model. Find out who actually holds it now — and decide for yourself who gets to hold it next.